Research Participants

Subjects come first for the BRANY Institutional Review Board (IRB). We are dedicated to protecting the rights and ensuring the welfare of all human research subjects, as evidenced by our commitment to ethical research and rigorous research oversight.

This section of our website provides current and potential research participants with useful information about participating in clinical trials, the protections they are entitled to, and a method to provide feedback and concerns about specific clinical trials.

 


Search Trials


Our Newest Trials

ENHANCE

Advanced or Metastatic Non-small Cell Lung Cancer

Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) POSITIVE AND NEGATIVE SOLID

Clinipace - Consellation - Phase 1 Solid Tumor

Allogeneic CRISPR-Cas9-Engineered T Cells (CTX130) in Adult Subjects

ER+ HER2- metastatic breast cancer

Non-Small Cell Lung Cancer PRA - Mirati - Krystal Program - 849-007

Progressive Familial Intrahepatic Cholestasis

Dyskinesia in Patients with Parkinson's Disease - PPD 88366-01